S. Shimazu

发表

sigma receptor ligands attenuate N-methyl-D-aspartate cytotoxicity in dopaminergic neurons of mesencephalic slice cultures.

A. Akaike, S. Kaneko, H. Katsuki, 2000, European journal of pharmacology.

Enhancer substances: selegiline and R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP] enhance the neurotrophic factor synthesis on cultured mouse astrocytes.

N. Sato, K. Hayashi, S. Shimazu, 2003, Life sciences.

Effects of selegiline on antioxidant systems in the nigrostriatum in rat

A. Akaike, H. Katsuki, S. Shimazu, 2006, Journal of Neural Transmission.

Recovery of motor function and dopaminergic parameters in a mouse model of Parkinson’s disease induced by co-administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate

S. Shimazu, F. Yoneda, Y. Iida, 2003, Journal of Neural Transmission.

Effects of monoamine oxidase inhibitors on the diethyldithiocarbamate-induced enhancement of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in C57BL/6 mice

S. Shimazu, F. Yoneda, Y. Iida, 2003, Journal of Neural Transmission.

Myocardial nerve fibers are preserved in MPTP-treated mice, despite cardiac sympathetic dysfunction

T. Uchihara, T. Amino, S. Orimo, 2008, Neuroscience Research.

Deprenyl rescues dopaminergic neurons in organotypic slice cultures of neonatal rat mesencephalon from N-methyl-D-aspartate toxicity.

A. Akaike, H. Katsuki, S. Shimazu, 1999, European journal of pharmacology.

Pharmacological studies with endogenous enhancer substances: β-phenylethylamine, tryptamine, and their synthetic derivatives

S. Shimazu, I. Miklya, 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

In vivo Imaging of Brain Dopaminergic Neurotransmission System in Small Animals with High-resolution Single Photon Emission Computed Tomography

H. Saji, H. Kawashima, M. Ogawa, 2003, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

Co-culture with the striatum attenuates N-methyl-D-aspartate cytotoxicity in dopaminergic neurons of rat mesencephalic slice cultures.

A. Akaike, S. Shimazu, T. Maeda, 1998, Japanese journal of pharmacology.

1-(Benzofuran-2-yl)-2-(3,3,3-trifluoropropyl)aminopentane HCl, 3-F-BPAP, antagonizes the enhancer effect of (-)-BPAP in the shuttle box and leaves the effect of (-)-deprenyl unchanged.

S. Shimazu, T. Yasusa, F. Yoneda, 2002, Life sciences.

Synthesis and in vitro cytotoxicity of 1,2,3,4-tetrahydroisoquinoline derivatives.

K. Taguchi, S. Shimazu, F. Yoneda, 2006, European journal of medicinal chemistry.

Antidepressant-like effects of selegiline in the forced swim test

A. Minami, S. Shimazu, F. Yoneda, 2005, European Neuropsychopharmacology.

Effects of selegiline alone or with donepezil on memory impairment in rats.

A. Minami, S. Shimazu, F. Yoneda, 2005, European journal of pharmacology.

Effects of subchronic treatment with selegiline on L-DOPA-induced increase in extracellular dopamine level in rat striatum.

H. Miwa, T. Kondo, S. Shimazu, 2006, Journal of pharmacological sciences.

The L-DOPA-sparing effect of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride [(-)-BPAP] in reserpine-pretreated rats.

S. Shimazu, F. Yoneda, J. Knoll, 2003, Life sciences.

Neuroprotective function of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane, [R-(-)-BPAP], against apoptosis induced by N-methyl(R)salsolinol, an endogenous dopaminergic neurotoxin, in human dopaminergic neuroblastoma SH-SY5Y cells.

M. Naoi, Tsutomu Takahashi, K. Iwasa, 2004, Life sciences.

Transfer of the von Hippel‐Lindau gene to neuronal progenitor cells in treatment for Parkinson's disease

Y. Kuroiwa, M. Baba, H. Sawada, 2003, Annals of neurology.

Superoxide dismutase activity in organotypic midbrain–striatum co‐cultures is associated with resistance of dopaminergic neurons to excitotoxicity

A. Akaike, H. Shirakawa, S. Kaneko, 2001, Journal of neurochemistry.

(-)-Deprenyl inhibits tyramine-induced noradrenaline release, but not tyramine-induced dopamine release or potassium-induced noradrenaline release, from rat brain synaptosomes.

S. Shimazu, F. Yoneda, K. Takahata, 2004, Pharmacological research.

(-)-1-(Benzofuran-2-yl)-2-propylaminopentane enhances locomotor activity in rats due to its ability to induce dopamine release.

A. Akaike, H. Katsuki, S. Shimazu, 2001, European Journal of Pharmacology.

Effects of R-(-)-BPAP on the expressions of neurotrophins and their receptors in mesencephalic slices.

A. Akaike, H. Katsuki, K. Hayashi, 2005, Biological & pharmaceutical bulletin.

Transporter-mediated actions of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane.

A. Janowsky, A. Akaike, H. Katsuki, 2003, European journal of pharmacology.

The novel catecholaminergic and serotoninergic activity enhancer R-(−)-1-(benzofuran-2-yl)-2-propylaminopentane up-regulates neurotrophic factor synthesis in mouse astrocytes

I. Mizuta, M. Ohta, S. Shimazu, 2002, Neuroscience Letters.